WB
M
Endogenous
24
Rabbit IgG
#Q7Z444
3266
Product Information
Product Usage Information
| Application | Dilution |
|---|---|
| Western Blotting | 1:1000 |
Storage
Specificity / Sensitivity
Species Reactivity:
Mouse
Source / Purification
Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Ala30 of human E-Ras protein.
Background
E-Ras (Embryonic Ras) is a member of the Ras family that includes K-Ras, N-Ras, and H-Ras. E-Ras is expressed in early mouse blastocysts and murine embryonic stem cells and is down-regulated upon differentiation (1). Amino acid substitutions as a result of mutation at three conserved positions in K-, H-, N-, and R-Ras proteins result in constitutive activation of these small GTPases, and oncogenic transformation. Intriguingly, the Eras gene encodes a protein where each of these amino acids are substituted, and so E-Ras is naturally constitutively active. E-Ras is thought to contribute to the tumorigenic potential of mouse ES cells to form teratomas in immunodeficient or isogenic mice (1). Despite the parallels between oncogenic mutated Ras, major differences in signaling exist between H-Ras G12V and E-Ras. While H-Ras G12V highly activates the MAPK pathway, E-Ras cannot bind to Raf1 to activate this pathway. Instead, E-Ras signals through PI3K to activate Akt (1). E-Ras is not expressed in human embryonic stem cells, nor is it is expressed in any adult tissues as found thus far (2). Reports have suggested it may be expressed in several tumor types, including gastric cancer (1,2,3). Researchers have speculated on the role of E-Ras in the early mouse blastocyst. Preimplantation embryos can survive in tissue culture in defined medium until the blastocyst stage without any requirement for serum or growth factors. Preimplantation embryos have a requirement for PI3K signaling, and in the absence of exogenous signals, E-Ras has been suggested to be the effector of this signal transduction (6).
- Takahashi, K. et al. (2003) Nature 423, 541-5.
- Kameda, T. and Thomson, J.A. (2005) Stem Cells 23, 1535-40.
- Kaizaki, R. et al. (2009) Anticancer Res 29, 2189-93.
- Kubota, E. et al. (2010) Am J Pathol 177, 955-63.
- Liu, Y. et al. (2013) Oncol Rep 30, 50-6.
- Gross, V.S. et al. (2005) Mol Reprod Dev 70, 324-32.
Species Reactivity
Species reactivity is determined by testing in at least one approved application (e.g., western blot).
Western Blot Buffer
IMPORTANT: For western blots, incubate membrane with diluted primary antibody in 5% w/v BSA, 1X TBS, 0.1% Tween® 20 at 4°C with gentle shaking, overnight.
Applications Key
WB: Western Blotting
Cross-Reactivity Key
H: human M: mouse R: rat Hm: hamster Mk: monkey Vir: virus Mi: mink C: chicken Dm: D. melanogaster X: Xenopus Z: zebrafish B: bovine Dg: dog Pg: pig Sc: S. cerevisiae Ce: C. elegans Hr: horse GP: Guinea Pig Rab: rabbit All: all species expected
Trademarks and Patents
Limited Uses
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.